Obregon Y - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trial.

Dragovich T, Burris H 3rd, Loehrer P, Von Hoff DD, Chow S, Stratton S, Green S, Obregon Y, Alvarez I, Gordon M. Dragovich T, et al. Among authors: obregon y. Am J Clin Oncol. 2008 Apr;31(2):157-62. doi: 10.1097/COC.0b013e31815878c9. Am J Clin Oncol. 2008. PMID: 18391600 Clinical Trial.

Phase I study of fixed dose gemcitabine plus epirubicin in patients with advanced solid malignancies.

Mahadevan D, Dreisbach L, Kristedja T, Williams D, Obregon Y, Kurtin S, Von Hoff DD. Mahadevan D, et al. Among authors: obregon y. Am J Clin Oncol. 2009 Dec;32(6):607-11. doi: 10.1097/COC.0b013e31819cc9ed. Am J Clin Oncol. 2009. PMID: 19593083 Clinical Trial.

Frequency and antimicrobial sensitivity of Ureaplasma urealyticum and Mycoplasma hominis in patients with vaginal discharge.

Díaz L, Cabrera LE, Fernández T, Ibáñez I, Torres Y, Obregón Y, Rivero Y. Díaz L, et al. Among authors: obregon y. MEDICC Rev. 2013 Oct;15(4):45-7. doi: 10.37757/MR2013V15.N4.11. MEDICC Rev. 2013. PMID: 24253351 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters